ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,67%
Bitcoin
66 821,63
2,43%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Principia Biopharma Inc (PRNB)

  7. Principia Biopharma Inc (PRNB) Actualités

PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRNB
DateHeureSourceTitreSymboleSociété
16/02/202121h14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
24/11/202014h00GlobeNewswire Inc.Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for RilzabrutinibNASDAQ:PRNBPrincipia Biopharma Inc
08/10/202013h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRNBPrincipia Biopharma Inc
01/10/202012h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202023h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202015h20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202015h12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014h49Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202012h35Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202012h31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
17/09/202014h01GlobeNewswire Inc.Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related DiseaseNASDAQ:PRNBPrincipia Biopharma Inc
10/09/202014h00GlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:PRNBPrincipia Biopharma Inc
28/08/202007h44Dow Jones NewsSanofi to Launch Tender Offer for Principia AcquisitionNASDAQ:PRNBPrincipia Biopharma Inc
25/08/202018h33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202012h01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRNBPrincipia Biopharma Inc
20/08/202022h20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRNBPrincipia Biopharma Inc
19/08/202019h50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202012h01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202009h02Dow Jones NewsSanofi Buys MS-Drug Development Partner -- WSJNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202019h51Dow Jones NewsSanofi to Buy U.S. Developer of Multiple Sclerosis Treatment -- 2nd UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202012h10Dow Jones NewsSanofi to Buy U.S. Developer of Multiple Sclerosis Treatment--UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202009h25Dow Jones NewsSanofi to Acquire US Company Principia Biopharma for $3.68 Billion -- UpdateNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202008h22Dow Jones NewsCorrection to Sanofi ArticleNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202008h06Dow Jones NewsSanofi to Acquire US Company Principia Biopharma for $3.68 BillionNASDAQ:PRNBPrincipia Biopharma Inc
17/08/202007h00PR Newswire (US)Sanofi to acquire Principia BiopharmaNASDAQ:PRNBPrincipia Biopharma Inc
06/08/202022h34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRNBPrincipia Biopharma Inc
06/08/202022h05GlobeNewswire Inc.Principia Biopharma Reports Second Quarter 2020 Financial ResultsNASDAQ:PRNBPrincipia Biopharma Inc
17/07/202008h29Dow Jones NewsSanofi Is Looking at US Biotech Acquisitions -BloombergNASDAQ:PRNBPrincipia Biopharma Inc
23/06/202007h15GlobeNewswire Inc.Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple SclerosisNASDAQ:PRNBPrincipia Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:PRNB

Dernières Valeurs Consultées

LSE
0DO1
Db X-trackers Ii Sh Ibox...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés